Finzati - Logo
AVXL logo

Anavex Life Sciences Corp.

AVXL • Biotechnology
$1.45
▲ +0.09 (+6.62%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$277.09M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 11.6Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 30, 2026, 12:06 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.45
Change6.62%
Market Cap$277.09M
52W Range2.25 - 10.40
Beta1.14
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio11.60
Quick Ratio11.60
Target$11.00

Investment DNA

How strong this company looks for long-term investors

36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
37/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 11.6Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-30
Low
$11.00
Mean
$11.00
Median
$11.00
High
$11.00

Company Overview

IPO: 8/2/2006
Industry: Biotechnology
P/B i: 8.00
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 11.60
Quick Ratio: 11.60
Status: Good

Insider Transactions

Recent executive and insider activity

⚠ 3 high-volume insider sells detected
Kellmeyer Terrie
Transaction: 05/04/2026
OTHER
Change
+50,000
Price
$8.58
Filing
05/14/2026
Type
OTHER
Paeger Axel
Transaction: 02/23/2026
OTHER
Change
0
Price
Not reported
Filing
05/01/2026
Type
OTHER
Boenisch Sandra
Transaction: 01/06/2026
BUY
Change
+12,500
Price
$8.58
Filing
01/09/2026
Type
BUY